BiotechTube
Portrett Pharmaceuticals

Portrett Pharmaceuticals

San Diego, United States· Est.
portrett.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Portrett Pharmaceuticals is a privately held, revenue-generating CRO founded in 2021, headquartered in Wilmington, North Carolina. The company operates a services-based business model, offering analytical testing to accelerate regulatory filings (IND, NDA, ANDA) for drug developers. With a core team boasting decades of combined industry experience, Portrett differentiates itself through a client-partnership approach and a guaranteed two-week turnaround time for testing results, aiming to reduce costs and delays for its clients.

OncologyRare Disease

Technology Platform

Operational process flow optimized for rapid turnaround (guaranteed two-week results) in cGMP-compliant analytical testing for small molecules, utilizing standard advanced instrumentation.

Opportunities

The growing trend of outsourcing by resource-constrained small and mid-size biopharma companies creates a strong demand for nimble, reliable CRO partners.
A continued high level of investment in oncology and rare disease R&D provides a targeted client base with urgent timeline needs that Portrett's model is designed to address.

Risk Factors

Operational risk is high, as any failure to meet the guaranteed turnaround time or maintain cGMP compliance could irreparably harm the company's reputation.
The business is also vulnerable to downturns in the biotech funding environment, which would directly reduce client spending on analytical services.

Competitive Landscape

Portrett competes against large, full-service global CROs (e.g., LabCorp, IQVIA, PPD) and smaller niche analytical labs. Its differentiation is its guaranteed two-week turnaround and focus on personalized service for small/mid-size clients, a segment often deprioritized by larger players where slower timelines are common.

More companies in Small Molecule Drugs →More companies in United States →